Six healthcare companies shrugged off the stock market chaos and filed for initial public offerings last week, totally $481 million. Who cares about trade wars and Fed policy when, as… Read more »
Schools of all categories will be starting sooner than many think, so time to get that last bit of summer vacation in and forget about real work. Oh, so that’s… Read more »
Three tech companies in the health sector entered the public market last week, raising a total of $601 million. Here are the proud IPOs and a glance at this week’s… Read more »
The second week of July continued the stampede among healthcare startups and seasoned players in search of new funding from Wall Street and, in one case, the Hong Kong exchange…. Read more »
The News: Germany’s BioNTech raises eye-popping €290M ($325M) in Series B round to fund personalized mRNA cancer vaccines, eschewing IPO for now. Just where does German biotech stand vis-à-vis the… Read more »
During the second quarter ending June 30, 62 IPOs raised $25.0 billion, the most active quarter by deal count in four years and the most capital raised in five years…. Read more »
Two healthcare companies raised $111M last week, and a jaw-dropping seven more filed with the SEC, adding to what has been a blistering May for IPOs. First, the pricings: 1)… Read more »
Trade war fears are crushing stocks, and the their swan dive onto the rocks could keep going if Presidents Trump and China’s Xi Jinping keep tossing tariff grenades at each… Read more »
Undaunted by the crushing weight of uncertainty affecting healthcare stock prices lately, the IPO action in New York continues to race ahead as though determined to prove Hong Kong’s budding… Read more »
It’s now Daylight Saving Time and the question on the heretofore gloomy minds of a lot of us healthcare stock editorialists is: Will it be boom or kaboom for IPOs… Read more »